Please try another search
| YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|---|---|
| Growth of 1000 | 1182 | 1072 | 1293 | 1972 | 1760 | 5564 |
| Fund Return | 18.15% | 7.19% | 29.33% | 25.4% | 11.97% | 18.72% |
| Place in category | - | - | - | - | - | - |
| % in Category | - | - | - | - | - | - |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| Rydex NASDAQ-100 Inv | 1.85B | 11.81 | 24.74 | 18.94 | ||
| Rydex Variable NASDAQ 100 2x Strate | 121.16M | 27.39 | 38.82 | 32.08 | ||
| Rydex Variable S P 500 2x Strategy | 136.31M | 21.12 | 33.19 | 22.17 | ||
| Rydex S&P 500 H | 176M | 1.30 | 19.11 | 13.62 | ||
| Rydex Variable NASDAQ 100 | 116.96M | 15.77 | 22.77 | 18.86 |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| Rydex Variable NASDAQ 100 2x Strate | 121.16M | 27.39 | 38.82 | 32.08 | ||
| Rydex Variable S P 500 2x Strategy | 136.31M | 21.12 | 33.19 | 22.17 | ||
| US7431857462 | 44.68M | 10.30 | 12.04 | 11.60 | ||
| ProFunds Ultra Dow 30 Investor | 45.01M | 35.36 | 14.24 | 16.81 | ||
| ProFund VP UltraBull | 32.53M | 21.49 | 33.04 | 21.96 |
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| Caterpillar | - | 10.12 | 570.79 | +0.05% | |
| Goldman Sachs | - | 9.62 | 877.52 | -1.57% | |
| UnitedHealth | - | 3.95 | 389.68 | -5.42% | |
| Microsoft | - | 3.55 | 506.24 | -2.27% | |
| Amgen | 31162100 | 3.44 | 457.93 | -0.95% |
| Type | Daily | Weekly | Monthly |
|---|---|---|---|
| Moving Averages | Strong Sell | Neutral | Buy |
| Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
| Summary | Strong Sell | Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review